High-risk human papillomavirus distribution in different cytological classification women

• Published in: Microbes and infection Vol. 25; no. 8; p. 105214
• Main Authors: Zheng, Li-Li, Zheng, Li-Yuan, Chen, Chao, Wang, Yi-Ting, Chen, Shuang-Feng, Zhong, Qian-Qian, Zhang, Yan, Li, Xue
• Format: Journal Article
• Language: English
• Published: France 01.11.2023
• Subjects: Early Detection of Cancer; Female; Genotype; Human papillomavirus 16 - genetics; Human papillomavirus 18 - genetics; Humans; Papillomaviridae - genetics; Papillomavirus Infections - diagnosis; Papillomavirus Infections - epidemiology; Retrospective Studies; Uterine Cervical Dysplasia - diagnosis; Uterine Cervical Dysplasia - pathology; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - pathology; Human papillomavirus; HPV DNA genotyping; Gynecological cancer; HPV E6/E7 mRNA testing; Cervical cancer
• ISSN: 1286-4579; 1769-714X; 1769-714X
• DOI: 10.1016/j.micinf.2023.105214

High-risk human papillomavirus (HR-HPV) infection is a major cause of infection-related cancer worldwide. 3101 HR-HPV-positive females were retrospectively analyzed and grouped using the cervical cytological screening (ThinPrep cytological test, TCT) evaluations combined with colposcopy. The HPV16 infection rate is the highest in all groups. HPV16 was the most frequent in each group, with significant differences between the four groups (χ  = 23.41, P = 0.0001). The distribution of HPV16 and HPV33 correlated with the pathologic stage in each group. The mixed infection rate of mRNA testing differs significantly between groups (P < 0.01, χ  = 17.44, P = 0.002). HR-HPV infection duration of less than six months accounted for 87.65%, 6 and 12 months of persistent infection (28.28%), and more than one year of continuous infection accounted for only 16.48%. The top three HPV types in a group with a duration of more than 12 months were HPV52 (3.03%), HPV16 (2.55%), and HPV39 (1.58%). The least clearance types were HPV39 (63.48%), 56 (69.54%), and 52 (71.44%) more than 12 months. This study revealed the region's primary pathogenic subtypes on different cervical lesions and provided the basis for diagnosing and treating HPV infection.